Search

Medical oncologist Chau Dang explains that patients living with metastatic breast cancer have more treatment options than ever before.

… Thursday, October 27, 2016 Summary Metastatic breast cancer is a challenging disease to treat, and for that reason there are many efforts focused on helping patients to live longer and with fewer side effects. Thanks to advances in clinical care, patients with metastatic breast cancer have more treatment

Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics.

… Friday, January 24, 2014 Summary Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics. Simon Powell, Chair of the Department of Radiation Oncology

MSK is a founding member of Break Through Cancer, a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers.

… Thursday, February 25, 2021 MSK today announced it is a founding member of Break Through Cancer , a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers. The foundation is being launched with a $250 million matching gift challenge

A Memorial Sloan Kettering Cancer Center study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation more effective and safe.

… Saturday, December 10, 2011 A Memorial Sloan Kettering Cancer Center study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation more effective and safe. Improving the effectiveness of such transplants, while at the same time reducing side effects, is an important

Despite the promise of eventually using artificial intelligence to detect melanoma, much more research and development are needed, MSK experts find.

… Thursday, May 19, 2022 When it comes to smartphone technologies, today there’s an app for just about everything: You can play chess, learn to speak Mandarin, or map the best driving route to the airport. Health is a huge category for apps, but many of these programs don’t have the science to back their

Cancer DNA taken from spinal fluid could serve as a liquid biopsy that provides information on brain tumor mutations.

… Wednesday, January 23, 2019 Summary Studying mutational changes that occur in brain tumors has been difficult. A new approach involves analyzing cancer DNA that the tumor sheds into the fluid surrounding the brain and spinal cord. This fluid can be collected in biopsies to help with diagnosis and choosing

The $50 million donation from Mike and Maria Repole and the Nonna’s Garden Foundation will support cancer care on Long Island and significantly advance research efforts.

… Monday, November 8, 2021 Memorial Sloan Kettering Cancer Center (MSK) today announced a generous $50 million gift from Mike and Maria Repole and the Nonna’s Garden Foundation to establish The Nonna’s Garden Foundation Initiative for Cancer Care and Research at MSK. The initiative will support several

The Thrivers event at Memorial Sloan Kettering celebrates Bone Marrow Transplant recipients on their return to health.

… Thursday, October 4, 2018 Family at BMT Thriver event Around 700 people joined the 23rd annual celebration for blood and marrow transplant thrivers at 583 Park Avenue, an event space in New York City. Bridget Anderson When Bridget Anderson learned there were no donor matches for a transplant to treat

The Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) at Memorial Sloan Kettering Cancer Center (MSK) today announced The Pat and Ian Cook Doctoral Program in Cancer Engineering, made possible by a generous gift of $15 million from Pat and Ian Cook.

… Tuesday, August 22, 2023 The Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) at Memorial Sloan Kettering Cancer Center (MSK) today announced The Pat and Ian Cook Doctoral Program in Cancer Engineering, made possible by a generous gift of $15 million from Pat and Ian Cook. This visionary

The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan Kettering Cancer Center research presented at the 49th annual meeting of the American Society of Clinical Oncology.

… Saturday, June 1, 2013 The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma , according to new Memorial Sloan Kettering Cancer Center research presented on Saturday, June 1, at the 49th annual meeting of